PGIMER issues notice on reporting, documents, security deposit submission for allotted MD, MS candidates

Published On 2021-12-25 05:00 GMT   |   Update On 2021-12-25 05:00 GMT

Chandigarh: Through a recent notice, the Post Graduate Institute of Medical Education & Research (PGIMER), has asked the MD/MS course candidates who have been allotted seats to report and submit documents, security deposits as per the stipulated timeline.

This is for information for the candidates who have been allotted seat through INI-CET at PGIMER, Chandigarh in the 1st Round of Online Seat Allocation for admission to MD/MS course (January 2022 Session) that the Reporting & Submission of Documents/ Security Deposit of Selected candidates will be accepted from 25.12.2021, 11:00 am to 28.12.2021 up to 05:00 PM including holidays, said the notification issued on the official website of PGIMER.

Advertisement

To view the official notice click on the following link:

https://medicaldialogues.in/pdf_upload/abstractfilepath-166771.pdf

Also Read:MD, MS Admissions At PGIMER: 28 Seats tentatively Available For Round 3 Counselling

The Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh was conceived in 1960 as a center of excellence which would endeavour to develop patterns of teaching in postgraduate medical education in as many branches as possible and attempt to produce specialists in several disciplines of medicine. It was also envisaged that these specialists would spread out in the country in various medical colleges and medical institutions and impart medical education of highest standard to the students and set up nucleus of excellence in their own institutions. The PGIMER was also given the responsibility to broaden the horizons of medical knowledge by intensive research in the field of health.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News